RELFY
LIVE

Serial Number

99743798

Owner

Galderma Holding SA

Attorney

Katherine P. Califa

Filing Date

Apr 3, 2026

Add to watchlist:

No watchlists yet
View on USPTO

RELFY Trademark

Serial Number: 99743798

RELFY is a trademark filed by Galderma Holding SA on April 3, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

Galderma Holding SA (96 trademarks)

Zählerweg 10

Entity Type: 33

Trademark Details

Filing Date

April 3, 2026

Registration Date

Not Registered

Goods & Services

Medical devices, namely, implants consisting of artificial materials in gel form used for filling wrinkles, folds, scars, lips, for face and body contour and skin rejuvenation; syringes for injections; injection devices for pharmaceutical products

Pharmaceutical preparations for use in dermatology; pharmaceutical preparations containing neurotoxins for use in dermatology; dermatological preparations; pre-filled syringes for medical purposes; injectable neurotoxins; medicated dermatological preparations and substances for the treatment of wrinkles, folds, scars, and lips, for face and body contour and skin rejuvenation; medicinal preparations for the treatment of bags under the eyes, dark circles, wrinkles, excess fat, tired and droopy eyes, loss of facial volume, sunken cheeks, reduced facial contours and structure, reduced skin quality, sun spots; pharmaceutical preparations containing neurotoxins for the treatment of bags under the eyes, dark circles, wrinkles, excess fat, tired and droopy eyes, loss of facial volume, sunken cheeks, reduced facial contours and structure, reduced skin quality, sun spots; injectable pharmaceutical products, namely, injectable dermal filler; injectable gels for use in the treatment and repair of joint cartilage; injectable dermal filler products, namely, injectable dermal fillers; pharmaceutical preparations containing neurotoxins for skin care; muscle relaxants; pharmaceutical preparations for the treatment of neurological disorders, muscle dystonia, headaches, wrinkles, hyperhidrosis, and pain

Filing History

APPLICATION FILING RECEIPT MAILED
Apr 3, 2026 MAFR
NEW APPLICATION ENTERED
Apr 3, 2026 NWAP